Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Gentronix
Gentronix
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
Gentronix's transgenic rodent mutation workflow accommodated with new lab
This continued growth follows a successful 2300 sqft expansion in 2021 to increase capacity of genetic, ocular, and skin toxicology testing in 2021
Finance
Gentronix adds capacity and services through laboratory expansion
The business has added a further 2,300 sqft to its footprint at Alderley Park in Cheshire
Finance
Gentronix expands dermal toxicology services
The addition of phototoxicity services, planned for Q2 2021, will enable the assessment of whether materials have adverse toxicity profiles after UV light activation
Regulatory
Gentronix expands sales teams in US and Europe
Appoints Dorothy Zelent and Simon Johns
Manufacturing
Gentronix signs genotoxicity assays agreement with GSK
Gentronix to provide GreenScreen HC and BlueScreen HC genotoxicity assays to GlaxoSmithKline (GSK).
Subscribe now